Label Value
DOI 10.1007/s10637-018-0627-4
TITLE Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2018-09-02T02:12:33.422906
Web of Science Yes 2019-04-12T03:52:48.570445
Compendex No 2020-12-23T16:43:54.385983